EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 44 / No 4 (Octobre-Décembre 2009) Radioprotection, 44 4 (2009) 431-446 References
Free Access
Issue
Radioprotection
Volume 44, Number 4, Octobre-Décembre 2009
Page(s) 431 - 446
DOI https://doi.org/10.1051/radiopro/2009015
Published online 09 December 2009
  • Ansoborlo E., Prat O., Moisy P., Den Auver C., Guilbaud P., Carriere M., Gouget B., Duffield J., Doizi D., Vercouter T., Moulin C., Moulin V. (2006) Actinide speciation in relation with biological processes, Biochimie 88, 1605-1618. [CrossRef] [PubMed] [Google Scholar]
  • Bhattacharyya M.H., Breitenstein B.D., Métivier H., Muggenburg B.A., Stradling G.N., Volf V. (1992) Guidebook for the treatment of accidental internal contamination of workers, Nuclear Technology Publishing, Ashford. [Google Scholar]
  • Breustedt B., Blanchardon E., Fritsch P., Giussani A., Lopez M.A., Luciani A., Malatova I., Nosske D., Piechowski J., Schimmelpfeng J., Sérandour A.-L. (2009) Biokinetic modeling of DTPA decorporation therapy: the CONRAD approach, Radiat. Prot. Dosim. 134, 38-48. [CrossRef] [Google Scholar]
  • FDA (2002) Food and Drug Administration, Guidance for industry on pentetate calcium trisodium and pentetate zinc trisodium for treatment of internal contamination with plutonium, americium or curium; availability, Federal Register 68, 53984-53988. [Google Scholar]
  • Fritsch P., Grappin L., Guillermin A.M., Fottorino R., Ruffin M., Mièle A. (2007) Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches, Radiat. Prot. Dosim. 127, 120-124. [CrossRef] [Google Scholar]
  • Fritsch P., Sérandour A.L., Grémy O., Phan G., Tsapis N., Abram M.C., Renault D., Fattal E., Benech H., Deverre J.R., Poncy J.L. (2009a) Simplified structure of a new model to describe urinary excretion of Pu after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments, Radiat. Res. 171, 674-686. [CrossRef] [PubMed] [Google Scholar]
  • Fritsch P., Sérandour A.L., Grémy O., Phan G., Tsapis N., Fattal E., Benech H., Deverre J.R., Poncy J.L. (2009b) Structure of a single model to describe plutonium and americium decorporation by DTPA treatment, Health Phys. (soumis). [Google Scholar]
  • Gervelas C., Sérandour A.L., Geiger S., Grillon G., Fritsch P., Taulelle C., Le Gall B., Benech H., Deverre J.R., Fattal E., Tsapis N. (2007) Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium, J. Control. Release 118, 78-86. [CrossRef] [PubMed] [Google Scholar]
  • Grappin L., Bérard P., Ménétrier F., Carbone L., Courtray C., Castagneux X., Le Golf J.P., Neron M.O., Piechowski J. (2007) Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants, Radiat. Prot. Dosim. 127, 435-439. [Google Scholar]
  • Grappin L., Bérard P. (2008) Autorisation de mise sur le marché du Ca-DTPA, Radioprotection 43, 465-466. [CrossRef] [EDP Sciences] [Google Scholar]
  • Grappin L., Legoff J.P., Carbone L., Courtay C., Agrinier A.L., Animat M., Amabile J.C., Florin A., André F. (2009) Traitement par le Ca-DTPA des contaminations internes par plutonium et américium : Recommandations pour la rédaction de protocoles dans les centres CEA et AREVA, Radioprotection 44, 447-461. [CrossRef] [EDP Sciences] [Google Scholar]
  • Hengé-Napoli M.H., Stradling G.N., Taylor D.M. (2000) Decorporation of radionuclides from the human body, Radiat. Prot. Dosim. 87, 11. [Google Scholar]
  • IUPAC (2004) Stability constants database, Academic Software, Timble, U.K. [Google Scholar]
  • James A.C., Sasser L.B., Stuit D.B., Glover S.E., Carbaugh E.H. (2007) USTUR whole body case 0269: demonstrating effectiveness of I.V. Ca-DTPA for Pu, Radiat. Prot. Dosim. 127, 114-119. [CrossRef] [Google Scholar]
  • Leggett R.W., Eckerman K.F., Khokhryakov V.F., Suslova K.G., Krahenbuhl M.P., Miller S.C. (2005) Mayak worker study: an improved biokinetic model for reconstructing doses from internally deposited plutonium, Radiat. Res. 164, 111-122. [CrossRef] [PubMed] [Google Scholar]
  • Ménétrier F., Grappin L., Raynaud P., Courtay C., Wood R., Joussineau S., List V., Stradling G.N., Taylor D.M., Bérard P., Morcillo M.A., Rencova J. (2005) Treatment of accidental intakes of plutonium and americium: guidance notes, Appl. Radiat. Isot. 62, 829-846. [CrossRef] [PubMed] [Google Scholar]
  • Mièle A., Blanchin N., Raynaud P., Quesne B., Giraud J.M., Fottorino R., Bérard P., Ansoborlo E., Franck D., Blanchardon E., Challeton-de Vathaire C., Lebaron-Jacobs L., Poncy J.L., Piechowski J., Fritsch P. (2007) MEDOR, a didactic tool to support interpretation of bioassay data after internal contamin Radiat. Prot. Dosim. 127, 350-355. [Google Scholar]
  • Roedler H.D., Nobke D., Ohlenschäger L., Schieferdecker H., Doerfel H., Renz K. (1989) Incorporation of 241Am: effectiveness of late chelation therapy, Radiat. Prot. Dosim. 26, 377-379. [Google Scholar]
  • Sérandour A.L., Grémy O., Fréchou M., Renault D., Poncy J.L., Fritsch P. (2008) In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early DTPA treatment, Radiat. Res. 170, 208-215. [CrossRef] [PubMed] [Google Scholar]
  • Sérandour A.L., Fritsch P. (2008) Pulmonary retention of actinides after dissolution of PuO2 aerosols: interest in modelling DTPA decorporation, Radioprotection 43, 239-254. [CrossRef] [EDP Sciences] [Google Scholar]
  • Stather J.W., Stradling G.N., Gray S.A., Moody J., Hodgson A. (1985) Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates, Hum. Toxicol. 4, 573-582. [CrossRef] [PubMed] [Google Scholar]
  • Stradling G.N., Stather J.W., Sumner S.A., Strong J.C., Lennox A.M., Ham S.E. (1984) Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA, Health Phys. 46, 919-924. [PubMed] [Google Scholar]
  • Taylor D.M., Hodgson S.A., Stradling N. (2007) Treatment of human contaminations with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective? Radiat. Prot. Dosim. 127, 469-471. [CrossRef] [Google Scholar]
  • Turner G.A., Taylor D.M. (1968) The transport of plutonium, americium and curium in the blood of rats, Phys. Med. Biol. 13, 535-546. [CrossRef] [PubMed] [Google Scholar]
  • Tymen H., Schoulz D., Caire-Maurisier A.M., Chevrier F., Curet P.M. (2000) Emergency treatment of pulmonary contaminations by transuranium elements. A new galenic form of Na3CaDTPA, Radioprotection 35, 473-485. [CrossRef] [EDP Sciences] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.